Home

Stryker Corp (SYK)

377.79
-14.94 (-3.80%)
NYSE · Last Trade: Aug 1st, 6:32 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close392.73
Open372.32
Bid370.00
Ask377.79
Day's Range372.32 - 383.09
52 Week Range314.93 - 406.19
Volume3,012,253
Market Cap142.46B
PE Ratio (TTM)51.05
EPS (TTM)7.4
Dividend & Yield3.360 (0.89%)
1 Month Average Volume1,181,462

Chart

About Stryker Corp (SYK)

Stryker Corporation is a leading medical technology company that specializes in designing, manufacturing, and marketing innovative products and services for healthcare professionals and patients. The company offers a diverse range of medical devices, including surgical equipment, orthopedic implants, neurotechnology, and surgery assistance products. Stryker focuses on advancing healthcare through cutting-edge technology and solutions that enhance patient care, improve surgical outcomes, and streamline hospital operations. With a commitment to innovation and quality, Stryker plays a pivotal role in the medical industry, helping healthcare providers deliver effective treatment and improve the quality of life for patients around the world. Read More

News & Press Releases

Stocks Sell Off, Gold Rallies On Tariff Turmoil, Weak Jobs Data: What's Moving Markets Friday?benzinga.com
It's a rough start to the new month for Wall Street, as major U.S. stock indices plunged by midday Friday, setting the stage for a negative weekly close.
Via Benzinga · August 1, 2025
Top S&P500 movers in Friday's pre-market sessionchartmill.com
Curious about the S&P500 stocks that are showing activity before the opening bell on Friday?
Via Chartmill · August 1, 2025
Beyond The Numbers: 4 Analysts Discuss Stryker Stockbenzinga.com
Via Benzinga · August 1, 2025
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?benzinga.com
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.
Via Benzinga · July 31, 2025
Earnings Scheduled For July 31, 2025benzinga.com
Via Benzinga · July 31, 2025
What Does the Market Think About Stryker?benzinga.com
Via Benzinga · July 30, 2025
A Look Into Stryker Inc's Price Over Earningsbenzinga.com
Via Benzinga · July 25, 2025
Stryker (NYSE:SYK) Surprises With Q2 Sales But Stock Drops
Medical technology company Stryker (NYSE:SYK) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 11.1% year on year to $6.02 billion. Its non-GAAP profit of $3.13 per share was 1.9% above analysts’ consensus estimates.
Via StockStory · July 31, 2025
What's going on in today's after hours session: S&P500 moverschartmill.com
Discover the top S&P500 movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · July 31, 2025
Stryker Corp (NYSE:SYK) Beats Q2 2025 Revenue and EPS Estimates but Shares Drop 4% in After-Hours Tradingchartmill.com
Stryker Corp (NYSE:SYK) beat Q2 2025 revenue and EPS estimates but shares fell 4% post-earnings. Strong MedSurg and Orthopaedics growth offset by market caution.
Via Chartmill · July 31, 2025
Stryker reports second quarter 2025 operating results
Portage, Michigan, July 31, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2025:
By Stryker Corporation · Via GlobeNewswire · July 31, 2025
Looking Into Stryker's Recent Short Interestbenzinga.com
Via Benzinga · July 11, 2025
How Do Investors Really Feel About Stryker?benzinga.com
Via Benzinga · June 25, 2025
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · July 31, 2025
Stryker (SYK) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Stryker (NYSE:SYK) will be reporting results this Thursday after market close. Here’s what you need to know.
Via StockStory · July 29, 2025
1 Mooning Stock on Our Watchlist and 2 We Question
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
Via StockStory · July 24, 2025
Many Think Doctors Are Overpaid And That's Why Healthcare Is So Pricey, But One U.S. Surgeon Actually Ran The Numbers Against Global Peersbenzinga.com
Via Benzinga · July 23, 2025
2 Unpopular Stocks That Should Get More Attention and 1 We Ignore
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Via StockStory · July 21, 2025
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · July 18, 2025
Rep. Thomas Kean Has Sold Up to $65K Worth Of Stryker Stock: Here's What You Should Knowbenzinga.com
Via Benzinga · July 17, 2025
The Analyst Verdict: Stryker In The Eyes Of 5 Expertsbenzinga.com
Via Benzinga · July 8, 2025
Here's How Much You Would Have Made Owning Stryker Stock In The Last 5 Yearsbenzinga.com
Via Benzinga · July 2, 2025
Stryker to announce financial results for its second quarter of fiscal year 2025
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025.  A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s second quarter that ended June 30, 2025.
By Stryker Corporation · Via GlobeNewswire · July 1, 2025
Stryker receives FDA clearance for Incompass Total Ankle System
Stryker (NYSE:SYK), a global leader in medical technologies, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Incompass® Total Ankle System, an implant intended for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis. This new platform integrates the innovative technologies of Stryker’s Inbone® and Infinity® systems into a single, comprehensive solution for total ankle replacement.
By Stryker · Via Business Wire · June 25, 2025
Stryker (SYK): Buy, Sell, or Hold Post Q1 Earnings?
Since December 2024, Stryker has been in a holding pattern, posting a small return of 1.1% while floating around $376.76.
Via StockStory · June 16, 2025